Mirae Asset Global ETFs Holdings
CHRS icon

Mirae Asset Global ETFs Holdings’s Coherus Oncology CHRS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$46.7K Sell
2025
Q1 		$53.8K Buy
2024
Q4 		$88.1K Buy
2024
Q3 		$62.1K Buy
2024
Q2 		$92.9K Buy